Citigroup Inc is building a new trading floor in Paris as the Wall Street giant prepares to nearly double its staff in the French capital.
The new floor in its existing building — located steps from the Avenue des Champs-Elysees and the Arc de Triomphe — would help Citigroup increase staffing for its trading division to 250 in the coming years, up from 130, said Fabio Lisanti, head of the bank’s trading business across Europe, excluding the UK.
The new floor is set to include at least 85 desks.
“It’s going to be a mixture of hiring and moves,” said Lisanti, who moved to Paris this month. “We will be bringing more traders here. The growth will come from trading and all the support functions around those — operations, legal, compliance — all the things that a trading floor needs.”
The expansion in Paris comes as Citigroup and rivals continue to grapple with life after Brexit, which forced Wall Street’s biggest banks to adjust operations to ensure they were trading European assets — from government bonds to interest-rate products to equities — within the 27 countries that remain in the EU.
“London remains the main trading hub for us,” Lisanti said. “But we have and will move certain risk management and risk books in Europe. We’ve already moved quite a few and there’s more to go.”
Citigroup ended last year with about 400 staffers in Paris, up from 170 immediately after Brexit.
Citigroup is just one of dozens of US financial firms that, after decades of using London as a gateway to Europe’s single market, are now opening offices or bolstering existing operations on the continent to keep their access to the bloc.
Paris has emerged as a key destination for banks, as its local traders, trained at the country’s elite universities, also often worked on the structuring of Societe Generale SA’s and BNP Paribas SA’s most complex derivative products.
Goldman Sachs Group Inc has grown from about 170 staff in 2017 to 350 at the end of last year in the country, with further hires expected next year. Morgan Stanley set up a research center to support its trading activities last year, while JPMorgan Chase & Co, whose Paris headquarters was a relative backwater with 250 staff until Brexit, boosted its local headcount to 800 at the end of last year and expanded its office footprint with a new modern extension.
UNCONVINCING: The US Congress questioned whether the company’s Chinese owners pose a national security risk and how the app might influence young users TikTok chief executive officer Shou Chew (周受資), confronted with an unforgiving, distrustful US Congress, tried to give answers in his testimony on Thursday that avoided offending either the US government or China. However, his evasiveness left Congress unsatisfied, with representatives hungrier than ever to punish TikTok for ties to its parent company ByteDance Ltd (字節跳動), based in Beijing. He did not bring his company any closer to a resolution. Politically, TikTok is in a tougher spot. Its executives had been discussing divesting from ByteDance to resolve US national security concerns, people familiar with the matter told Bloomberg. However, China this week said
Microsoft Corp has threatened to cut off access to its Internet search data, which it licenses to rival search engines, if they do not stop using it as the basis for their own artificial intelligence (AI) chat products, people familiar with the dispute have said. The software maker licenses the data in its Bing search index — a map of the Internet that can be quickly scanned in real time — to other companies that offer Web search, such as Apollo Global Management Inc’s Yahoo and DuckDuckGo. Last month, Microsoft integrated a cousin of ChatGPT, OpenAI’s AI-powered chat technology, into Bing. Rivals
Sanofi SA’s drug Dupixent succeeded in a late-stage trial for chronic obstructive pulmonary disease (COPD), raising the odds that the blockbuster would be the first biologic medicine cleared to treat the lung disorder. Dupixent, which is already prescribed for asthma and some skin conditions, showed a 30 percent reduction in the rate at which patients’ COPD worsened compared with those who received a placebo during the stage-three Boreas trial, the company said in a statement yesterday. The positive data could herald a new era of cutting-edge treatments for the life-threatening respiratory affliction and provide another major boost in demand for the French
SEMICONDUCTOR EQUIPMENT: The international trade group said the sector would recover from a slump, with spending expected to rise 4.2 percent to US$24.9 billion Taiwan is to retain its position as the top spender on semiconductor front-end equipment and facilities next year, with spending expected to increase 4.2 percent year-on-year to US$24.9 billion, international trade group SEMI said yesterday. The spending forecast matches an expected recovery in global semiconductor equipment and facilities investment next year, it said. International equipment spending is to return to growth next year, SEMI said in a report, forecasting 21 percent growth to US$92 billion. The expansion would manly be driven by robust demand for semiconductors in the automotive and high-performance computing segments, the association said. “This quarter’s SEMI World Fab Forecast update
RSS